It’s a followup to the Wired article Algorithms Take Control of Wall Street.
It’s a followup to the Wired article Algorithms Take Control of Wall Street.
The market is now punishing unprofitable companies
In June, the American Society of Clinical Oncology (ASCO) hosted its 60th Annual Meeting, drawing over 40,000 attendees from around the globe. This year’s event largely focused on validating revolutionary treatment categories like Chimeric antigen receptor (CAR) T-cell therapies and antibody drug conjugates (ADCs). Given proven clinical benefits across a wider array of cancer types, we expect these novel treatment categories to become increasingly important in the fight against cancer and the growth profiles of select companies in the healthcare space.
In December 2023, Global X Research surveyed 1,002 individuals in the United States regarding their sentiments toward clean technology.
The remarkable progress in humanoid technology, fueled by groundbreaking technical advancements and cost reductions, signals the potential for disruptive shifts across industries. Despite current challenges in combining mobility and cognitive abilities, we expect innovation to continue and broad-ased adoption to follow.